HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Canada NHP license regs in effect

This article was originally published in The Tan Sheet

Executive Summary

Health Canada implements the Natural Health Products Unprocessed Product License Applications Regulations, effective Aug. 4, to allow dietary supplements, homeopathics and other NHPs an expedited path to market. In a 1letter, the agency calls the regulations "a temporary solution" - in effect for 30 months - by which applicants seeking a natural health product number instead can receive an exemption number if Health Canada fails to license or reject a product within 180 days (2"The Tan Sheet" June 21, 2010). The agency faces a sizable backlog of license applications and expects the UPLARs to "provide for the legal sale of nearly 12,000 NHPs" that fit a minimum safety profile. The regulations came after Canadian pharmacists objected to Health Canada allowing NHPs with pending licenses to reach retail

You may also be interested in...



Canada Proposes Temporary Expedited Approval For Natural Health Products

Health Canada moves to liberalize, at least temporarily, the approval process by which natural health products come to market to assuage concerns about retailer liability

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS135051

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel